Literature DB >> 33717084

The Roles of Sclerostin in Immune System and the Applications of Aptamers in Immune-Related Research.

Meiheng Sun1,2,3, Zihao Chen4, Xiaoqiu Wu1,2,3, Yuanyuan Yu1,2,3, Luyao Wang1,2,3, Aiping Lu1,2,3,5,6, Ge Zhang1,2,3, Fangfei Li1,2,3.   

Abstract

Wnt signaling is one of the fundamental pathways that play a major role in almost every aspect of biological systems. In addition to the well-known influence of Wnt signaling on bone formation, its essential role in the immune system also attracted increasing attention. Sclerostin, a confirmed Wnt antagonist, is also proven to modulate the development and differentiation of normal immune cells, particularly B cells. Aptamers, single-stranded (ss) oligonucleotides, are capable of specifically binding to a variety of target molecules by virtue of their unique three-dimensional structures. With in-depth study of those functional nucleic acids, they have been gradually applied to diagnostic and therapeutic area in immune diseases due to their various advantages over antibodies. In this review, we focus on several issues including the roles of Wnt signaling and Wnt antagonist sclerostin in the immune system. For the sake of understanding, current examples of aptamers applications for the immune diseases are also discussed. At the end of this review, we propose our ideas for the future research directions.
Copyright © 2021 Sun, Chen, Wu, Yu, Wang, Lu, Zhang and Li.

Entities:  

Keywords:  B cell malignancies; Wnt signaling pathway; aptamers; immune system; sclerostin

Year:  2021        PMID: 33717084      PMCID: PMC7946814          DOI: 10.3389/fimmu.2021.602330

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  97 in total

1.  Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling.

Authors:  Xiaofeng Li; Yazhou Zhang; Heeseog Kang; Wenzhong Liu; Peng Liu; Jianghong Zhang; Stephen E Harris; Dianqing Wu
Journal:  J Biol Chem       Date:  2005-03-18       Impact factor: 5.157

2.  Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein.

Authors:  M E Brunkow; J C Gardner; J Van Ness; B W Paeper; B R Kovacevich; S Proll; J E Skonier; L Zhao; P J Sabo; Y Fu; R S Alisch; L Gillett; T Colbert; P Tacconi; D Galas; H Hamersma; P Beighton; J Mulligan
Journal:  Am J Hum Genet       Date:  2001-02-09       Impact factor: 11.025

3.  Frizzled 9 knock-out mice have abnormal B-cell development.

Authors:  Erik A Ranheim; Helen C K Kwan; Tannishtha Reya; Yu-Ker Wang; Irving L Weissman; Uta Francke
Journal:  Blood       Date:  2004-11-30       Impact factor: 22.113

4.  Antibody targeting of B-cell maturation antigen on malignant plasma cells.

Authors:  Maureen C Ryan; Michelle Hering; David Peckham; Charlotte F McDonagh; Lindsay Brown; Kristine M Kim; Damon L Meyer; Roger F Zabinski; Iqbal S Grewal; Paul J Carter
Journal:  Mol Cancer Ther       Date:  2007-11       Impact factor: 6.261

5.  SOST Gene Inhibits Osteogenesis from Adipose-Derived Mesenchymal Stem Cells by Inducing Th17 Cell Differentiation.

Authors:  Li You; Lin Chen; Ling Pan; Yongde Peng; Jinyu Chen
Journal:  Cell Physiol Biochem       Date:  2018-07-24

6.  Genetic deletion of Sost or pharmacological inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth.

Authors:  J Delgado-Calle; J Anderson; M D Cregor; K W Condon; S A Kuhstoss; L I Plotkin; T Bellido; G D Roodman
Journal:  Leukemia       Date:  2017-05-22       Impact factor: 11.528

7.  Regulatory effect of Act1 on the BAFF pathway in B-cell malignancy.

Authors:  Xiao-Jun Ge; Yong-Lun Wang; Yang Ping Wu; Zhong-Xin Feng; Lan Liu; Mei Yong Li; Jun-Yao Jiang
Journal:  Oncol Lett       Date:  2019-02-18       Impact factor: 2.967

8.  An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery.

Authors:  Silvia Catuogno; Maria Teresa Di Martino; Silvia Nuzzo; Carla Lucia Esposito; Pierfrancesco Tassone; Vittorio de Franciscis
Journal:  Mol Ther Nucleic Acids       Date:  2019-10-28       Impact factor: 8.886

Review 9.  Wnt Signaling in the Regulation of Immune Cell and Cancer Therapeutics.

Authors:  Muhammad Haseeb; Rameez Hassan Pirzada; Qurat Ul Ain; Sangdun Choi
Journal:  Cells       Date:  2019-11-03       Impact factor: 6.600

10.  Rituximab-specific DNA aptamers are able to selectively recognize heat-treated antibodies.

Authors:  Michael Kohlberger; Sabrina Wildner; Christof Regl; Christian G Huber; Gabriele Gadermaier
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

View more
  2 in total

Review 1.  Sclerostin is a promising therapeutic target for oral inflammation and regenerative dentistry.

Authors:  Chufang Liao; Shanshan Liang; Yining Wang; Ting Zhong; Xiangning Liu
Journal:  J Transl Med       Date:  2022-05-13       Impact factor: 8.440

Review 2.  Drug discovery of sclerostin inhibitors.

Authors:  Sifan Yu; Dijie Li; Ning Zhang; Shuaijian Ni; Meiheng Sun; Luyao Wang; Huan Xiao; Dingdong Liu; Jin Liu; Yuanyuan Yu; Zongkang Zhang; Samuel Tin Yui Yeung; Shu Zhang; Aiping Lu; Zhenlin Zhang; Baoting Zhang; Ge Zhang
Journal:  Acta Pharm Sin B       Date:  2022-01-21       Impact factor: 14.903

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.